Results 121 to 130 of about 273,783 (254)
ABSTRACT Blinatumomab, a CD19xCD3 bispecific T‐cell engager, has become standard therapy for children with de novo B‐cell acute lymphoblastic leukemia (B‐ALL). This retrospective review describes the experience of blinatumomab administration in pediatric patients.
Julia M. Hurley +6 more
wiley +1 more source
Cancer: a looming public health crisis in Africa-a call to accelerate equitable access to medicines. [PDF]
Anorlu RI +7 more
europepmc +1 more source
Access to medicines through global health diplomacy. [PDF]
Chattu VK +3 more
europepmc +1 more source
ABSTRACT We report a retrospective single‐center analysis of pediatric patients with relapsed or refractory B‐cell precursor acute lymphoblastic leukemia focusing on relapses outside of the typical locations, bone marrow, central nervous system, or testes.
Johanna Kunz +7 more
wiley +1 more source
Access to Medicines in Bulgaria and North Macedonia: Legislative, Pricing, and Reimbursement Perspectives. [PDF]
Todorova A +4 more
europepmc +1 more source
ABSTRACT Background Together, leukemia and lymphoma account for 38.7% of newly diagnosed pediatric cancer cases in the United States each year. Many caregivers utilize online resources to inform medical health decisions. Understanding the readability of these materials is critical to ensuring comprehensible patient education.
Chloe Strege +6 more
wiley +1 more source
Socioeconomic Determinants of Access to Medicines Among Romanian Patients with Chronic Diseases: A Cross-Sectional Study. [PDF]
Negrila CD +3 more
europepmc +1 more source
Children's access to medicines [PDF]
Access to health care for children is important. It is dependent on access to health professionals and also parental attitudes towards illness. Children have the right to receive medicines that are scientifically evaluated for both efficacy and safety.
openaire +1 more source

